Top Markets
Coin of the day
Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF
Rankning i aktier #41805
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$9.87K
Förändring (1 dag)
0.00%
Förändring (1 år)
-99.79%
Land
CA
Handel Valeo Pharma Inc. (VPHIF)

Kategori

Aktiekurshistorik för Valeo Pharma Inc. (VPHIF)
Högsta slutkurs: $0.00 den 2026-08-01

Lägsta slutkurs: $0.85 den 2020-09-01
Aktiekurshistorik för Valeo Pharma Inc. från 2020 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 -99.79%
2024 -64.24%
2023 -71.62%
2022 -18.52%
2021 -36.53%
2020 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$165.41 27.23%
DE
$36.27 22.59%
JP
$229.68 41.61%
CH
$21.43 14.29%
IN